You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HBsAg Loss

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chronic Hepatitis b, Anti-PD-1 Antibody, Peg-IFNa Trial in Chongqing (Anti-PD-1 antibody, NAs, Peg-IFNa)

Not yet recruiting
  • Chronic Hepatitis b
  • +2 more
  • Anti-PD-1 antibody
  • +2 more
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 14, 2023

Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)

Not yet recruiting
  • Chronic Hepatitis b
  • Anti-PD-1 Antibody
  • Anti-PD-1 antibody
  • NAs
  • Chongqing, Chongqing, China
    The 2nd affiliated Hospital of Chongqing Medical University
Mar 3, 2023

Hepatitis B, Chronic Trial in Worldwide (Entecavir (ETV), Tenofovir Disoproxil Fumarate (TDF), Tenofovir Alafenamide (TAF))

Withdrawn
  • Hepatitis B, Chronic
  • Entecavir (ETV)
  • +2 more
  • Kolding, Denmark
  • +29 more
Oct 27, 2022

Chronic Hepatitis B Trial in Amsterdam (Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir

Completed
  • Chronic Hepatitis B
  • Peg-Interferon alfa 2a + Adefovir dipivoxil, Peg-Interferon alfa 2a + Tenofovir disoproxil fumarate
  • Amsterdam, Noord-Holland, Netherlands
    Academic Medical Center
Mar 25, 2021

HBsAg Declined Patients Follow-up Study

Not yet recruiting
  • Hepatitis B
  • Hepatitis B, Chronic
    • (no location specified)
    Jul 28, 2023

    Chronic Hepatitis B (HBeAg-negative) Trial (Pegylated interferon alfa-2a)

    Completed
    • Chronic Hepatitis B (HBeAg-negative)
    • Pegylated interferon alfa-2a
    • (no location specified)
    Sep 4, 2019

    Chronic Hepatitis b Trial in Lyon (procedure, biological, other)

    Not yet recruiting
    • Chronic Hepatitis b
    • Investigation of the intrahepatic compartment using the fine needle aspiration (FNA) technique
    • +2 more
    • Lyon, France
      Hepatology Department - Hospices Civils de Lyon
    Sep 14, 2023

    Chronic Hepatitis B Trial (Bepirovirsen, Placebo)

    Recruiting
    • Chronic Hepatitis B
    • Herston, Queensland, Australia
    • +7 more
    Jan 23, 2023

    Chronic Hepatitis B Trial in Worldwide (Bepirovirsen, Placebo)

    Recruiting
    • Chronic Hepatitis B
    • Victoria, British Columbia, Canada
    • +10 more
    Jan 23, 2023

    Hepatitis B, HIV Trial in Worldwide (Selgantolimod, Placebo)

    Recruiting
    • Hepatitis B
    • HIV Infections
    • San Diego, California
    • +35 more
    Jan 31, 2023

    Chronic Hepatitis B Trial in Zhengzhou (continuous treatment, pulse therapy)

    Recruiting
    • Chronic Hepatitis B
    • continuous treatment
    • pulse therapy
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Jul 13, 2022

    Chronic Hepatitis B Trial in Zhengzhou (PegIFN a- 2b)

    Completed
    • Chronic Hepatitis B
    • PegIFN α- 2b
    • Zhengzhou, Henan, China
      Henan Provincial People's Hospital
    Jul 11, 2022

    Hepatitis B, Chronic Trial in Beijing (Granulocyte Macrophage-colony Stimulating Factor, Entecavir)

    Terminated
    • Hepatitis B, Chronic
    • Granulocyte Macrophage-colony Stimulating Factor
    • Entecavir
    • Beijing, Beijing, China
      302 Military Hospital
    Mar 9, 2022

    Chronic Hepatitis B Trial in Seoul (Standard of care)

    Active, not recruiting
    • Chronic Hepatitis B
    • Standard of care
    • Seoul, Korea, Republic of
    • +3 more
    Mar 29, 2023

    Hepatitis B, Chronic Trial in Worldwide (administration of SLGN in arm C, Discontinuation of NUC treatment in arms B and C)

    Recruiting
    • Hepatitis B, Chronic
    • administration of SLGN in arm C
    • Discontinuation of NUC treatment in arms B and C
    • Lyon, France
    • +7 more
    Mar 11, 2022

    Hepatitis B, Chronic Trial in Worldwide (Stop of therapy)

    Active, not recruiting
    • Hepatitis B, Chronic
    • Stop of therapy
    • København, Denmark
    • +10 more
    Sep 13, 2021

    Hepatocellular Carcinoma Trial in Hong Kong (Durvalumab, Sorafenib, Lenvatinib)

    Recruiting
    • Hepatocellular Carcinoma
    • Hong Kong, Hong Kong SAR, Hong Kong
      Humanity & Health Research Centre
    Mar 16, 2022

    Chronic Hepatitis B Trial in Hong Kong (Stop current treatment (anti-HBV neucleos(t)ides), Keep current treatment (anti-HBV

    Recruiting
    • Chronic Hepatitis B
    • Stop current treatment (anti-HBV neucleos(t)ides)
    • Keep current treatment (anti-HBV neucleos(t)ides)
    • Hong Kong, Hong Kong SAR, Hong Kong
      Humanity & Health Research Centre
    Mar 16, 2022

    Hepatitis B, Chronic Trial in Auckland (VIR-3434, VIR-2218, TDF)

    Recruiting
    • Hepatitis B, Chronic
    • Auckland, New Zealand
    • +1 more
    Dec 19, 2022

    Chronic Hepatitis B Infection, Chronic Hepatitis D Infection Trial in Taipei City, Taipei city, Taoyuan city (P1101 + Nivolumab

    Recruiting
    • Chronic Hepatitis B Infection
    • Chronic Hepatitis D Infection
    • P1101 + Nivolumab + Entecavir
    • Taipei City, Taiwan
    • +3 more
    Sep 15, 2021

    Hepatitis B Trial in Cambridge (GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide, GSK's HBsAg candidate vaccine

    Recruiting
    • Hepatitis B
    • GSK's Hepatitis B vaccine adjuvanted with aluminum hydroxide
    • +4 more
    • Cambridge, United Kingdom
      GSK Investigational Site
    Jan 12, 2023

    HBV Infection, Chronic Hepatitis b Trial in China (Tenofovir Amibufenamide(TMF))

    Recruiting
    • HBV Infection
    • Chronic Hepatitis b
    • Tenofovir Amibufenamide（TMF）
    • Beijing, China
    • +11 more
    Mar 22, 2023

    Predictive Model for Prognosis of Chronic HBV Infection Mothers

    Recruiting
    • Hepatitis B, Chronic
    • Age, BMI,Baseline HBV DNA, Baseline HBeAg level, Baseline HBsAg level, Antiviral treatment, Serum ALT level
    • Xi'an, Shaanxi, China
      First Affiliated Hospital of Xi'an Jiaotong University
    Aug 20, 2021

    Chronic Hepatitis B Virus Infection Trial in Worldwide (PEG-IFNa, BRII-835)

    Not yet recruiting
    • Chronic Hepatitis B Virus Infection
    • Kingswood, New South Wales, Australia
    • +28 more
    Jul 21, 2023

    Chronic Hepatitis B Trial (RO7565020, Placebo, Nucleos(t)ide analogue (NUC) treatment)

    Not yet recruiting
    • Chronic Hepatitis B
    • (no location specified)
    Feb 28, 2023